Abstract

MACROADENOMA IN PREGNANCY, SUCCESSFUL MANAGEMENT WITH CABERGOLINE: A CASE REPORT.

Pinky Jena*, Shilpa Venkatesh and Vani Ramkumar

Abstract

Hyperprolactinemia is a common cause for anovulation and infertility. When evaluated appropriately and treated with dopamine agonist, pregnancy can be achieved easily. Here, we report the case of a 25 year old nulliparous lady who presented to us with secondary amenorrhea and was diagnosed to have pituitary macroadenoma. Cabergoline was intitiated and the patient conceived within three months. After conception, cabergoline was discontinued and bromocriptine was initiated. Due to nontolerance, patient was restarted on cabergoline that was continued till delivery. It was stopped postpartum to allow for lactation. The lady and her infant are under follow up. Conclusion: Cabergoline may be used safely and effectively during pregnancy to treat macroadenoma without causing any fetal malformations. By this case report, we hope to contribute to the relatively meagre data available on use of cabergoline in pregnancy and its outcome.

Keywords: Hyperprolactinemia, Macroadenoma, Bromocriptine & Cabergoline.